Genomic advances for gene discovery in hereditary hearing loss

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 23, Issue 3, 2012, Pages 93-97

  Avraham, Karen B ^a   Kanaan, Moien ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b BETHLEHEM UNIVERSITY   (Palestine)

Author keywords

Consanguineous; Deafness; Homozygosity mapping; Massively parallel sequencing; Next generation sequencing

Indexed keywords

GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOMICS; HEARING IMPAIRMENT; HIGH THROUGHPUT SEQUENCING; HOMOZYGOSITY; HUMAN; REVIEW;

DEAFNESS; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HOMOZYGOTE; HUMANS;

EID: 84867799233     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2012-0033     Document Type: Review

References (29)

1. Morton CC, Nance WE. Newborn hearing screening - a silent revolution. N Engl J Med 2006;354:2151 - 64.
2. Petit C, Richardson GP. Linking genes underlying deafness to hair-bundle development and function. Nat Neurosci 2009;12: 703 - 10.
3. Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S, et al. From flies ' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci USA 2002;99:7518 - 23.
4. Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet 1998;62:27 - 35.
5. Leon PE, Raventos H, Lynch E, Morrow J, King MC. The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl Acad Sci USA 1992;89:5181 - 4.
6. Guilford P, Ben Arab S, Blanchard S, Levilliers J, Weissenbach J, Belkahia A, et al. A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet 1994;6:24 - 8.
7. Raviv D, Dror AA, Avraham KB. Hearing loss: a common disorder caused by many rare alleles. Ann NY Acad Sci 2010;1214:168 - 79.
8. Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 1987;236:1567 - 70.
9. Gilissen C, Hoischen A, Brunner HG, Veltman JA. Unlocking Mendelian disease using exome sequencing. Genome Biol 2011;12:228.
10. Tranchevent LC, Capdevila FB, Nitsch D, De Moor B, De Causmaecker P, Moreau Y. A guide to web tools to prioritize candidate genes. Brief Bioinform 2011;12:22 - 32.
11. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80 - 3.
12. Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997;6:2173 - 7.
13. Scott CA, Kelsell DP. Key functions for gap junctions in skin and hearing. Biochem J 2011;438:245 - 54.
14. Rodriguez-Paris J, Pique L, Colen T, Roberson J, Gardner P, Schrijver I. Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assessment of its diagnostic value for medical practice. PLoS One 2010;5: e11804.
15. Kothiyal P, Cox S, Ebert J, Husami A, Kenna MA, Greinwald JH, et al. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnol 2010;10:10.
16. Gymrek M, Erlich Y. Using DNA sequencers as stethoscopes. Genome Med 2011;3:73.
17. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010;11:31 - 46.
18. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008;9:387 - 402.
19. Rehman AU, Morell RJ, Belyantseva IA, Khan SY, Boger ET, Shahzad M, et al. Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet 2010;86:378 - 88.
20. Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W, et al. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 2010;87:90 - 4.
21. Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Rayyan AA, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 2011;12:R89.
22. Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 2010;107:21104 - 9.
23. Brownstein Z, Bhonker Y, Avraham KB. High-throughput sequencing to decipher the genetic heterogeneity of deafness. Genome Biol 2012;13:245.
24. Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012;21:2205 - 10.
25. Shearer AE, Hildebrand MS, Sloan CM, Smith RJ. Deafness in the genomics era. Hear Res 2011;282:1 - 9.
26. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I, et al. Whole-genome sequencing for optimized patient management. Sci Trans Med 2011;3:87re3.
27. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13: 255 - 62.
28. Sacheli R, Delacroix L, Vandenackerveken P, Nguyen L, Malgrange B. Gene transfer in inner ear cells: a challenging race. Gene Ther 2012; doi: 10.1038/gt.2012.51. Available at: http://www.nature.com/gt/journal/vaop/ ncurrent/full/gt201251a.html.
29. Atar O, Avraham KB. Therapeutics of hearing loss: expectations vs. reality. Drug Discov Today 2005;10:1323 - 30.